Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Stock
€19.80
0.000%
The stock is an absolute favorite of our community with 27 Buy predictions and no Sell predictions.
Based on the current price of 19.8 € the target price of 57 € shows a potential of 187.88% for Ultragenyx Pharmaceutical Inc. which would more than double the current price.
